Encouraging Participation And Transparency In Biobank Research
- 1 August 2018
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 37 (8), 1313-1320
- https://doi.org/10.1377/hlthaff.2018.0159
Abstract
Medical biobanks often struggle to obtain sustainable funding. Commercialization of specimens is one solution, but disclosure of commercial interests to potential contributors can be dissuasive. Recent revisions to the federal human subjects research regulations will soon mandate such commercialization disclosure in some circumstances, which raises questions about implications for practice. In this nationally representative, probability-based survey sample of the US adult population, we found that 67 percent of participants agreed that clear notification of potential commercialization of biospecimens is warranted, but only 23 percent were comfortable with such use. Sixty-two percent believed that profits should be used only to support future research, and 41 percent supported sharing profits with the public. We also considered other factors related to disclosure in our analysis and argue for a "disclosure plus" standard: informing potential contributors that their biospecimens might be accessed by commercial organizations and explaining how profits would be used to both enhance transparency and facilitate contributors' altruistic motivations.Keywords
This publication has 29 references indexed in Scilit:
- Neglected ethical issues in biobank management: Results from a U.S. studyLife Sciences, Society and Policy, 2013
- Cancer patient perceptions on the ethical and legal issues related to biobankingBMC Medical Genomics, 2013
- Identifying Personal Genomes by Surname InferenceScience, 2013
- Involving citizens in the ethics of biobank research: Informing institutional policy through structured public deliberationSocial Science & Medicine (1982), 2012
- Occupational Injury in America: An analysis of risk factors using data from the General Social Survey (GSS)Journal of Safety Research, 2012
- We’re not in it for the money—lay people’s moral intuitions on commercial use of ‘their’ biobankMedicine, Health Care and Philosophy, 2011
- Mistrust of Health Care Organizations Is Associated with Underutilization of Health ServicesHealth Services Research, 2009
- The Obligation to Participate in Biomedical ResearchPublished by American Medical Association (AMA) ,2009
- Trust in Physicians and Medical Institutions: What Is It, Can It Be Measured, and Does It Matter?The Milbank Quarterly, 2001
- Ethical aspects of clinical trials: the attitudes of participants in two non-cancer trialsJournal of Internal Medicine, 2000